A specific point of contention, which is driving the latest legal challenge, concerns the transfer of assets – including MetaMask and Infura – from the original Switzerland-based company ConsenSys AG to a U.S.-based company, ConsenSys Software Inc. (CSI), which was spun out in early 2020 around the time the COVID-19 pandemic was hitting.